Form 8-K - Current report:
SEC Accession No. 0001144204-15-000810
Filing Date
2015-01-06
Accepted
2015-01-06 16:01:56
Documents
26
Period of Report
2015-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v398157_8-k.htm 8-K 15942
2 EXHIBIT 99.1 v398157_ex99-1.htm EX-99.1 45064
3 GRAPHIC image_001.jpg GRAPHIC 43167
4 GRAPHIC image_002.jpg GRAPHIC 126377
5 GRAPHIC image_003.jpg GRAPHIC 127675
6 GRAPHIC image_004.jpg GRAPHIC 107374
7 GRAPHIC image_005.jpg GRAPHIC 135026
8 GRAPHIC image_006.jpg GRAPHIC 118795
9 GRAPHIC image_007.jpg GRAPHIC 121965
10 GRAPHIC image_008.jpg GRAPHIC 138853
11 GRAPHIC image_009.jpg GRAPHIC 129355
12 GRAPHIC image_010.jpg GRAPHIC 109063
13 GRAPHIC image_011.jpg GRAPHIC 136704
14 GRAPHIC image_012.jpg GRAPHIC 169573
15 GRAPHIC image_013.jpg GRAPHIC 110502
16 GRAPHIC image_014.jpg GRAPHIC 88340
17 GRAPHIC image_015.jpg GRAPHIC 89287
18 GRAPHIC image_016.jpg GRAPHIC 96821
19 GRAPHIC image_017.jpg GRAPHIC 110952
20 GRAPHIC image_018.jpg GRAPHIC 142034
21 GRAPHIC image_019.jpg GRAPHIC 137270
22 GRAPHIC image_020.jpg GRAPHIC 134953
23 GRAPHIC image_021.jpg GRAPHIC 123692
24 GRAPHIC image_022.jpg GRAPHIC 124516
25 GRAPHIC image_023.jpg GRAPHIC 73050
26 GRAPHIC image_024.jpg GRAPHIC 119836
  Complete submission text file 0001144204-15-000810.txt   3944563
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 15510000
SIC: 2834 Pharmaceutical Preparations